Precigen (NASDAQ:PGEN) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.08) by 125 percent. This is a 80 percent decrease over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $1.34 million which beat the analyst consensus estimate of $500.00 thousand by 168.20 percent. This is a 25.92 percent increase over sales of $1.06 million the same period last year.